Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Amneal Pharmaceuticals, Inc.
Business Segments
Business Segments
Deferred income and reimbursable research and development services
Deferred income and reimbursable research and development services
Amneal Pharmaceuticals, Inc.
·
Business Segments
·
1 segment
Breakdown
Segments
Affordable Medicines
View metric
Watchlist
Screener
Filings
Earnings
Charts
Annual
Segment
FY'25
Affordable Medicines
$4.1M
Total
$4.1M
All segment values are derived from annual filings.